Aurobindo Pharma gets USFDA nod for its expectorant tablets
Posted by
www.biotecnika.org
The company has received final approval from the United States Food
and Drug Administration (USFDA) to manufacture its generic Guaifenesin
extended-release tablets in the strengths of 600 mg and 1,200 mg.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/aurobindo-pharma-gets-usfda-nod-for-its-expectorant-tablets/articleshow/71740775.cms
Subscribe to:
Post Comments (Atom)
Post a Comment